Bill
S 3271
Bill S 3271 ensures health insurance covers remotely connected insulin pens for eligible diabetes patients, improving monitoring and health outcomes.
Title: Provides coverage for remotely connected insulin pens for certain patients with diabetes
Bill Number: S 3271
Status: Referred to Health
Introduced: January 24, 2025
Classification: Bill
Bill S 3271 aims to enhance diabetes management for patients by ensuring that certain individuals have access to coverage for remotely connected insulin pens. These advanced devices allow for better monitoring and administration of insulin, which can lead to improved health outcomes for patients with diabetes.
Coverage Requirement: The bill mandates that health insurance plans provide coverage for remotely connected insulin pens for patients diagnosed with diabetes who meet specific criteria.
Eligibility Criteria: The bill specifies that eligible patients must demonstrate a medical necessity for the use of these devices, which may include factors such as the type of diabetes, frequency of insulin administration, and overall health condition.
Device Specifications: The bill outlines that the insulin pens must be capable of connecting to digital health platforms, enabling better tracking of insulin usage and glucose levels.
Cost Sharing: The legislation may include provisions regarding cost-sharing for patients, ensuring that out-of-pocket expenses are manageable for those who require these devices.
Patients with Diabetes: Individuals diagnosed with diabetes who require insulin therapy and could benefit from the enhanced monitoring capabilities of remotely connected insulin pens.
Health Insurance Providers: Insurance companies will need to adjust their coverage policies to comply with the new requirements set forth by this bill.
Healthcare Providers: Physicians and diabetes care specialists will need to familiarize themselves with the new devices and their integration into patient care plans.
Current Status: As of January 24, 2025, the bill has been referred to the Health Committee for further consideration.
Related Legislation: This bill is related to previous legislative efforts, including:
Bill S 3271 represents a significant step towards improving diabetes management through technology. By providing coverage for remotely connected insulin pens, the bill aims to enhance the quality of care for patients with diabetes, potentially leading to better health outcomes and reduced complications associated with the disease. The bill is currently under review by the Health Committee, and its progress will be closely monitored by stakeholders in the healthcare community.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
